Aug 13, 2026 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update
Aug 12, 2026 8:17 am EDT Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients
Aug 11, 2026 4:10 pm EDT VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update
Aug 5, 2026 8:17 am EDT Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
Jul 7, 2026 8:17 am EDT VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test
Jun 3, 2026 8:12 am EDT VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring
May 27, 2026 8:17 am EDT VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
